MYC and cancer: Subsequently, non-phosphorylated β-catenin in the nucleus binds to the transcription factor T-cell factor/lymph enhancer factor (TCF/LEF) to activate the downstream cellular myelocytomatosis viral oncogene (c-Myc), leading to cancer cell proliferation and differentiation (Zhang and Wang, 2020; Nalli et al., 2022).